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Patients with HIV-1 and HTLV-2 coinfections often
exhibit a clinical course similar to HIV-1 infected long-
term nonprogressors. This observation has been attribu-
ted in part to the ability of the HTLV Tax2 protein to
activate production of antiviral chemokines and to down-
regulate the CCR5 co receptor on lymphocytes. Therefore
we investigated the possibility that a recombinant Tax2
protein could suppress HIV-1 viral replication in vitro.
R5-tropic HIV-1 (NLAD8)-infected-PBMCs were treated
daily with recombinant Tax1 and Tax2 proteins (dosage
range 1-100 pM). Culture supernatants were collected at
intervals for 22 days post-infection and assayed for levels
of HIV-1 p24 antigen. Treatment of PBMCs with Tax2
protein resulted in significant reduction in HIV-1 p24
antigen levels (p<0.05) at days 10, 14, and 18 post-infec-
tion compared to HIV-1-infected or mock-treated
PBMCs. This was preceded by the detection of increased
levels of CC-chemokines MIP-1a/CCL3, MIP-1b/CCL4,
and RANTES/CCL5, on days 1-7 of infection (p<0.05).
Similar, but less robust inhibition was determined in
Tax1 treated PBMCs. Addition of Tax2 proteins starting
48 hours previous to infection resulted in a significant
inhibition of HIV-1 p24 levels (p<0.05 at days 7 to 14
compared to the untreated, R5 infected PBMCs. In con-
trast, when addition of Tax2 began two days after R5
infection, significant HIV-1 p24 levels were only deter-
mined at days 7 and 10 for 1 pM and at day 7 for 10 pM
(p<0.05). These results support the contention that Tax1
and Tax2 play a role in generating antiviral responses
against HIV-1 in vivo and in vitro.
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